首页> 外文OA文献 >PRM4 Enhancing the Health Economic Value of Retrospective and Prospective Real-World Studies with Pharmacogenomic Testing: Opportunities and Challenges Associated with an Integrated Personalized Medicine Approach

【2h】

PRM4 Enhancing the Health Economic Value of Retrospective and Prospective Real-World Studies with Pharmacogenomic Testing: Opportunities and Challenges Associated with an Integrated Personalized Medicine Approach

机译：PRM4通过药物基因组学测试提高回顾性和前瞻性现实世界研究的健康经济价值：与综合个性化医学方法相关的机遇和挑战

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Payne K.A.; Frueh F.W.; Sohal J.;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Personalized medicine: part 3: challenges facing health care plans in implementing coverage policies for pharmacogenomic and genetic testing. [J] . Vogenberg FR, Barash CI, Pursel M P & T: a peer-reviewed journal for formulary management . 2010,第12期

机译：个性化医学：第3部分：在实施药物基因组学和基因检测的覆盖政策时，医疗保健计划面临的挑战。
2. Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: A report of the ISPOR personalized medicine special interest group [J] . FaulknerE., AnnemansL., GarrisonL., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2012,第8期

机译：个性化药品付款人和制造商的观点在发展和报销方面的挑战以及对健康经济学和结果研究的影响：ISPOR个性化医学特别兴趣小组的报告
3. Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine [J] . Ji, Si, Y., Expert Review of Molecular Diagnostics . 2018,第1a6期

机译：下一代测序时代的临床药学试验：精密药物的挑战和机遇
4. Technical Challenges and Opportunities When Implementing Pharmacogenomics Decision Support Integrated in the Electronic Health Record [C] . Pedro J. Caraballo, Joseph A. Sutton, Ann M. Moyer, MEDINFO . 2017

机译：在电子健康记录中实施药物替代科学决策支持时的技术挑战和机遇
5. A Clinical Decision Support Model for Incorporating Pharmacogenomics Knowledge Into Electronic Health Records for Drug Therapy Individualization: A Microcosm of Personalized Medicine. [D] . Overby, Casey Lynnette. 2011

机译：将药物基因组学知识整合到电子健康记录中以进行药物治疗个性化的临床决策支持模型：个性化医学的一个缩影。
6. Economic concerns about global healthcare in lung head and neck cancer: meeting the economic challenge of predictive preventive and personalized medicine [O] . Christine Ausweger, Eva Burgschwaiger, Andrea Kugler, 2010

机译：关于全球肺癌头颈癌医疗保健的经济问题：应对预测预防和个性化医学的经济挑战
7. Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group [O] . Faulkner Eric, Annemans Lieven, Garrison Lou, 2012

机译：个性化药物开发和报销方面的挑战—支付者和制造商的观点以及对健康经济学和结果研究的启示：ISPOR个性化医学特别兴趣小组的报告

PRM4 Enhancing the Health Economic Value of Retrospective and Prospective Real-World Studies with Pharmacogenomic Testing: Opportunities and Challenges Associated with an Integrated Personalized Medicine Approach

著录项

引文网络

相似文献

相关主题

期刊订阅